Sökresultat

Collaboration, networking, career development, and wellbeing. Those are four examples of needs that the newly formed young MultiParkers working group will address. After organizing their first event, they are eager to start preparing for more events. During the pandemic, there has been an upbuild of need for social gathering and exchange of ideas and experiences. Especially young researchers who r

https://www.multipark.lu.se/article/young-multiparkers-working-group-takes-shape - 2026-07-11

Receiving grants from the Swedish Research Council is viewed as a quality mark and one of the critical steps for young scientists to establish an independent research group. Last week, nine of MultiPark’s research leaders were awarded 31.6 million SEK for their projects. This year’s support from the Swedish Research Council encouraged MultiPark’s ambition to be a multidisciplinary research area. P

https://www.multipark.lu.se/article/nine-multipark-scientists-granted-support-swedish-research-council - 2026-07-11

During his research education, Jonathan Timpka wanted to elucidate what is affecting the ability to work for patients diagnosed with Parkinson’s disease. Defending his Ph.D. thesis on November 19th, Jonathan tells about his wide range of projects within the Restorative Parkinson Unit led by Per Odin. Tell us about your Ph.D. research! My research engagement has been quite diverse, ranging from reg

https://www.multipark.lu.se/article/phd-defence-interview-jonathan-timpka - 2026-07-11

Gene expression inside Parkinson’s disease patient’s brain cells seems to trigger structural changes of the Parkinson-linked protein alpha-synuclein. This was discovered when MultiPark researchers converted skin cells from Parkinson patients into midbrain cells in the dish. The study was published in Acta Neuropathologica Communications. Parkinson’s disease (PD) is a neurodegenerative disorder lin

https://www.multipark.lu.se/article/environment-inside-brain-cells-holds-clues-protein-aggregation - 2026-07-11

Emil Ygland Rödström is defending his thesis on the 20th of November. His research is about clinical, genetical, and biochemical biomarkers for the prognosis of Parkinson’s disease patients. Here, he tells us more about the discoveries and his time as a Ph.D. student in the Clinical Neurogenetics group at MultiPark. What is your research about? My thesis work consists of two different parts. In th

https://www.multipark.lu.se/article/phd-defence-interview-emil-ygland - 2026-07-11

Presently many of Sweden’s 20,000 Parkinson’s patients are not receiving the treatment they need, and many of the most seriously ill receive incorrect or inappropriate therapy. With the new Manage PD tool and the PD Pal study, Per Odin, professor at Lund University and senior attending physician at Skåne University Hospital in Lund, hopes to be able to improve the care of Parkinson’s patients. Eve

https://www.multipark.lu.se/article/faster-and-better-treatment-parkinsons-disease-manage-pd-tool - 2026-07-11

Inflammation researcher Ben King studies the function of two different proteins in connection with diabetes. In the future, such knowledge may be important for the development of new treatments for people with diabetes. Ben King is this year’s recipient of the Medeon Award for his innovative research. “I was very surprised and feel very honored to receive the award. In my role, I do a lot of exper

https://www.ludc.lu.se/article/award-protein-research-may-lead-new-treatments-diabetes - 2026-07-11

We would like to congratulate six researchers at Lund University Diabetes Centre, who have been awarded research grants within medicine and health by the Swedish Research Council (VR). The six researchers are affiliated with Excellence of Diabetes Research in Sweden (EXODIAB), which is a strategic research area within diabetes at Lund University.Helena Elding Larsson, professor of autoimmune disea

https://www.ludc.lu.se/article/six-ludc-researchers-receive-medicine-and-health-grants-vr - 2026-07-11

An international team of researchers has investigated whether oral insulin can prevent early signs of type 1 diabetes and clinical diagnosis in children with an increased risk of developing the disease. Although treatment with oral insulin could not prevent development of diabetes-related autoantibodies, oral insulin delayed the rate of disease progression in children who developed such autoantibo

https://www.ludc.lu.se/article/oral-insulin-delayed-onset-type-1-diabetes-some-children-increased-risk-disease - 2026-07-11

This article is over 5 years old, and the information may therefore be outdated. Social and economic factors have led to a dramatic rise in type 2 diabetes and obesity around the world. In a review in Science, Mark McCarthy, professor at the University of Oxford, UK, and Paul Franks, professor at Lund University, Sweden, examine the knowledge of the actual causes and the interplay between genetics

https://www.ludc.lu.se/article/review-type-2-diabetes-and-obesity-what-do-we-really-know - 2026-07-11

Diabetes researchers at Lund University have previously shown that people with diabetes can be stratified into five subgroups with differing disease progression. A new study by the same researchers provides increased evidence for the clinical relevance of the classification system. The researchers also present new findings of significant differences between subgroups in the development of complica

https://www.ludc.lu.se/article/new-research-classification-diabetes-identifies-high-risk-group - 2026-07-11

How can a tiny genetic change alter the body´s sugar balance? At Lund University, researchers have used stem cells to create two versions of the same cell – one carrying the genetic variant and one without – to see how melatonin affects insulin-producing cells and contributes to development of type 2 diabetes. Study summarySkin cells from a person carrying a risk gene for type 2 diabetes were “rep

https://www.ludc.lu.se/article/stem-cell-technology-reveals-new-insights-melatonin-and-diabetes - 2026-07-11

DIABETES. After more than a decade of stagnation, there is a major surge in kidney research effort. New drugs and biomarkers make it possible to detect and slow the progression of the disease earlier – something that long seemed unattainable. This will impact people with diabetes, for whom kidney damage is a serious long-term complication. “We are entering a new era. What is happening now is simil

https://www.ludc.lu.se/article/hope-kidney-care - 2026-07-11

Three research groups at Lund University Diabetes Centre receive new project grants within precision medicine. The aim with the projects is to develop individualised treatment strategies that may benefit people with type 2 diabetes. One of the new projects will investigate whether it is possible to develop individualised treatment strategies for people with type 2 diabetes. The project EPIPREDIA i

https://www.ludc.lu.se/article/precision-medicine-research-within-type-2-diabetes-and-dementia-receives-support - 2026-07-11

For the first time, researchers have been able to show how a cell closes the door to free radicals – small oxygen molecules that are sometimes needed, but that can also damage our cells. The study is published in Nature Communications and was led from Lund University. For our cells to function, they need to maintain a careful balance between beneficial and harmful oxygen molecules known as free ra

https://www.ludc.lu.se/article/capturing-moment-cell-shuts-door-free-radicals - 2026-07-11

Laura Elo at University of Turku is awarded the Leif C. Groop Award for outstanding research on type 1 diabetes. The mathematician from Finland has developed methods which have helped increase the understanding of how type 1 diabetes develops at molecular level. She hopes her research will help prevent and delay the progression of the disease and individualise the treatment of type 1 diabetes. Jus

https://www.ludc.lu.se/article/laura-elo-awarded-leif-c-groop-award-outstanding-research-type-1-diabetes - 2026-07-11

Metabolic dysfunction-associated steatotic liver disease (MASLD) can cause more serious liver conditions, such as liver failure. A new study, led by Lund University in Sweden, presents new data that may lead to better disease management and prevention of in the future. The international research team identified an altered expression of specific genes in samples from individuals with obesity, MASLD

https://www.ludc.lu.se/article/new-research-identifies-potential-treatment-target-fatty-liver-disease - 2026-07-11

In an international study, researchers at Lund University in Sweden have identified a gene variant that controls the body’s capability to form new blood vessels in muscles – a mechanism that affects physical performance, health and recovery. The favourable gene variant is considerably more common among top athletes in endurance sports, compared with both top athletes in explosive sports and non-at

https://www.ludc.lu.se/article/genetic-brake-forms-our-muscles - 2026-07-11

Studies of the gut microbiota can provide new knowledge about human health and how the risk of developing various diseases is affected. Marju Orho-Melander at Lund University is one of the authors of two new articles in Nature Genetics which have discovered several new gene variants in the human genome which may influence which bacteria are found in the gut. Some of the new gene variants can be li

https://www.ludc.lu.se/article/mapping-gene-variants-which-affect-gut-microbiota-and-disease-risk - 2026-07-11

This article is over 5 years old, and the information may therefore be outdated. Lund University Diabetes Centre has entered into a collaboration with the Regeneron Genetics Center LLC (RGC) and the University of Helsinki involving exome-sequencing and whole genome array genotyping of greater than 9,000 individuals. The collaboration will involve the largest sequencing study in diabetes families t

https://www.ludc.lu.se/article/lund-initiates-genetic-sequencing-study-diabetes-families-provide-new-insights-what-causes-disease - 2026-07-11